s6y

INTEGRATED BIOPHARMA INC

Ticker
INBP
CIK
1016504
Industry
Pharmaceutical Preparations
Formerly
INTEGRATED HEALTH TECHNOLOGIES INC, CHEM INTERNATIONAL INC

Financials 110

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-K Annual Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-Q Quarterly Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-K Annual Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-Q Quarterly Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-K Annual Report for period ending Jun 30, 2024

All 110 financials filings

News 157

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 157 news filings

Ownership 168

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4/A Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4/A Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 168 ownership filings

Prospectus 15

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. S-3/A Registration statement for specified transactions by certain issuers
  4. S-3/A Registration statement for specified transactions by certain issuers
  5. S-3/A Registration statement for specified transactions by certain issuers
  6. S-3 Registration statement for specified transactions by certain issuers
  7. RW Registration Withdrawal Request
  8. S-3 Registration statement for specified transactions by certain issuers
  9. S-3/A Registration statement for specified transactions by certain issuers
  10. S-3 Registration statement for specified transactions by certain issuers

All 15 prospectus filings

Proxies 46

  1. DEF 14A Definitive proxy statements
  2. DEF 14A Definitive proxy statements
  3. DEF 14A Definitive proxy statements
  4. DEF 14A Definitive proxy statements
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements
  7. DEF 14A Definitive proxy statements
  8. DEF 14A Definitive proxy statements
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 46 proxies filings

Other 63

  1. SCHEDULE 13D
  2. SCHEDULE 13D/A
  3. D Exempt (Private) Offering
  4. ARS Annual report to security holders
  5. 25 Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
  6. UPLOAD Letter (PDF)
  7. EFFECT Notice of Effectiveness
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. UPLOAD Letter (PDF)
  10. UPLOAD Letter (PDF)

All 63 other filings